Literature DB >> 18832551

Evaluation and treatment of hypertension in general pediatric practice.

Alexis Boneparth1, Joseph T Flynn.   

Abstract

Hypertension (HTN) in children and adolescents has become increasingly common. We sought to identify variability in the approach to HTN among general pediatricians as well as obstacles to care of hypertensive youth by surveying pediatricians referring to an urban children's hospital. Although most pediatricians begin blood pressure measurement at 3 years, there was substantial variability in the initial diagnostic evaluation of hypertensive patients. Just 7% of pediatricians routinely start antihypertensive drug treatment for HTN, whereas 82% refer their hypertensive patients to a specialist; 40% of pediatricians felt uncomfortable evaluating and treating HTN. Pediatricians unfamiliar with The Fourth Report were more likely to be uncomfortable with the care of hypertensive patients than those familiar with it (54% vs 33%, P < .05). Current practice does not appear to follow recent consensus recommendations. Interventions designed to address the issues identified in this survey may lead to improved care for pediatric patients with HTN.

Entities:  

Mesh:

Year:  2008        PMID: 18832551     DOI: 10.1177/0009922808321677

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  16 in total

1.  Pediatric Hypertension Specialists' Perspectives About Adolescent Hypertension Management: Implications for Primary Care Providers.

Authors:  Esther Yoon; Brigitte McCool; Stephanie Filipp; Albert Rocchini; David Kershaw; Sarah Clark
Journal:  Clin Pediatr (Phila)       Date:  2014-11-13       Impact factor: 1.168

2.  Antihypertensive prescribing patterns for adolescents with primary hypertension.

Authors:  Esther Y Yoon; Lisa Cohn; Albert Rocchini; David Kershaw; Gary Freed; Frank Ascione; Sarah Clark
Journal:  Pediatrics       Date:  2011-12-05       Impact factor: 7.124

3.  Underlying Rationale and Approach to Treat Hypertension in Adolescents by Physicians of Different Specialty.

Authors:  Esther Y Yoon; Julie S Weber; Brigitte McCool; Albert Rocchini; David Kershaw; Gary Freed; Frank Ascione; Sarah Clark
Journal:  Ann Pediatr Child Health       Date:  2013

4.  The effect of an electronic health record-based tool on abnormal pediatric blood pressure recognition.

Authors:  Sarah A Twichell; Corinna J Rea; Patrice Melvin; Andrew J Capraro; Joshua C Mandel; Michael A Ferguson; Daniel J Nigrin; Kenneth D Mandl; Dionne Graham; Justin P Zachariah
Journal:  Congenit Heart Dis       Date:  2017-05-11       Impact factor: 2.007

Review 5.  Updated Guideline May Improve the Recognition and Diagnosis of Hypertension in Children and Adolescents; Review of the 2017 AAP Blood Pressure Clinical Practice Guideline.

Authors:  Janis M Dionne
Journal:  Curr Hypertens Rep       Date:  2017-10-16       Impact factor: 5.369

Review 6.  Evaluation of hypertension in children.

Authors:  Gaurav Kapur; Rossana Baracco
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

7.  Time to referral to a nephrology clinic for pediatric hypertension.

Authors:  Tyler Hamby; Matthew R Pueringer; Sahil Noorani; Alisha Khanna; Julie Barrow; Randa Razzouk
Journal:  Pediatr Nephrol       Date:  2020-02-14       Impact factor: 3.714

Review 8.  Rational use of antihypertensive medications in children.

Authors:  Michael A Ferguson; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

Review 9.  Assessment and management of hypertension in children and adolescents.

Authors:  Brian W McCrindle
Journal:  Nat Rev Cardiol       Date:  2010-01-12       Impact factor: 32.419

10.  Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension.

Authors:  Esther Y Yoon; Lisa Cohn; Gary Freed; Albert Rocchini; David Kershaw; Frank Ascione; Sarah Clark
Journal:  J Adolesc Health       Date:  2014-02-01       Impact factor: 5.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.